Traws Pharma, Inc., a clinical─stage biopharmaceutical company developing novel therapies to target critical threats to human health from...

Traws Pharma, Inc., a clinical─stage biopharmaceutical company developing novel therapies to target critical threats to human health from...

Alzheimer’s disease affects millions of people around the world, but women are far more likely than men to be diagnosed with the condition. Many...

Alzheimer’s disease affects millions of people around the world, but women are far more likely than men to be diagnosed with the condition. Many...

Alzheimer’s disease remains one of the most feared illnesses of our time, impacting more than six million people in the United States alone. With no...

FRIDAY, Oct. 3, 2025 -- For patients with mild-to-moderate knee osteoarthritis (OA), a single course of low-dose radiation therapy leads to a...

Follow-up analysis from Argenica’s Phase II stroke trial shows promising functional improvements in patients treated with ARG-007. ...

Follow-up analysis from Argenica’s Phase II stroke trial shows promising functional improvements in patients treated with ARG-007. ...

Business Wire India   For Trade and Medical Media Only Enrolment completed in Phase III ReSPECT study in prophylaxis of fungal infections in adult...

Her late mother was diagnosed with the disease in 2003. ......